Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Sell
1,231
-48
-4% -$65.8K 0.21% 97
2025
Q4
$1.63M Buy
1,279
+199
+18% +$208K 0.39% 46
2025
Q3
$1.05M Sell
1,080
-225
-17% -$177K 0.24% 96
2025
Q2
$1.05M Buy
1,305
+140
+12% +$100K 0.2% 115
2025
Q1
$772K Sell
1,165
-817
-41% -$594K 0.19% 123
2024
Q4
$1.37M Buy
1,982
+487
+33% +$350K 0.37% 64
2024
Q3
$1.25M Buy
1,495
+258
+21% +$231K 0.4% 54
2024
Q2
$1.27M Buy
1,237
+292
+31% +$281K 0.51% 44
2024
Q1
$917K Buy
+945
New +$838K 0.53% 44

Other funds holding ASML

Gibbs Wealth Management's ASML Position: Q1 2026 in Review

Gibbs Wealth Management reduced its ASML (ASML) stake by 3.8% in Q1 2026, selling an estimated $65.8K and leaving 1,231 shares worth $1.63M. The position accounts for 0.21% of the portfolio, ranked #97.

Gibbs Wealth Management first reported a position in ASML in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.63M in Q4 2025. 2,188 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

  • Gibbs Wealth Management held 1,231 shares of ASML worth $1.63M as of Q1 2026.
  • Gibbs Wealth Management sold 48 ASML shares in Q1 2026, an estimated $65.8K.
  • ASML made up 0.21% of Gibbs Wealth Management's portfolio in Q1 2026, its #97 holding.
  • Gibbs Wealth Management first reported a position in ASML in Q1 2024 and has held it in 9 quarters since.
  • Gibbs Wealth Management's ASML position peaked at $1.63M in Q4 2025.
  • 2,188 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.